WallStreetZenWallStreetZen

NASDAQ: PYPD
Polypid Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PYPD

Based on 3 analysts offering 12 month price targets for Polypid Ltd

Min Forecast
$9.00+163.93%
Avg Forecast
$11.00+222.58%
Max Forecast
$13.00+281.23%

Should I buy or sell PYPD stock?

Based on 3 analysts offering ratings for Polypid Ltd.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PYPD stock forecasts and price targets.

PYPD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-09
lockedlocked$00.00+00.00%2025-06-05
lockedlocked$00.00+00.00%2025-04-14

1 of 1

Forecast return on equity

Is PYPD forecast to generate an efficient return?

Company
27.85%
Industry
140.91%
Market
90.47%
PYPD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PYPD forecast to generate an efficient return on assets?

Company
8.49%
Industry
32.45%
PYPD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PYPD earnings per share forecast

What is PYPD's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.88-138.29%
Avg 2 year Forecast
-$0.89-118.02%
Avg 3 year Forecast
-$0.51-110.39%

PYPD revenue forecast

What is PYPD's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.4M
Avg 2 year Forecast
$36.6M
Avg 3 year Forecast
$81.2M

PYPD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PYPD$3.41$11.00+222.58%Strong Buy
ESLA$0.96$16.00+1,566.67%Strong Buy
PLUR$4.40$12.00+172.73%Strong Buy
LVTX$1.31$1.50+14.50%Hold
MDCX$2.60$23.50+803.85%Strong Buy
View Top Biotech Stocks

Polypid Stock Forecast FAQ

Is Polypid Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PYPD) stock is to Strong Buy PYPD stock.

Out of 3 analysts, 1 (33.33%) are recommending PYPD as a Strong Buy, 2 (66.67%) are recommending PYPD as a Buy, 0 (0%) are recommending PYPD as a Hold, 0 (0%) are recommending PYPD as a Sell, and 0 (0%) are recommending PYPD as a Strong Sell.

If you're new to stock investing, here's how to buy Polypid stock.

What is PYPD's earnings growth forecast for 2025-2027?

(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Polypid's earnings in 2025 is -$29,022,000.On average, 2 Wall Street analysts forecast PYPD's earnings for 2025 to be -$19,158,900, with the lowest PYPD earnings forecast at -$19,260,809, and the highest PYPD earnings forecast at -$19,056,990. On average, 2 Wall Street analysts forecast PYPD's earnings for 2026 to be -$9,018,950, with the lowest PYPD earnings forecast at -$11,108,085, and the highest PYPD earnings forecast at -$6,929,815.

In 2027, PYPD is forecast to generate -$5,197,361 in earnings, with the lowest earnings forecast at -$5,197,361 and the highest earnings forecast at -$5,197,361.

What is PYPD's revenue growth forecast for 2026-2028?

(NASDAQ: PYPD) Polypid's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Polypid's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PYPD's revenue for 2026 to be $34,649,074, with the lowest PYPD revenue forecast at $34,649,074, and the highest PYPD revenue forecast at $34,649,074. On average, 1 Wall Street analysts forecast PYPD's revenue for 2027 to be $372,987,086, with the lowest PYPD revenue forecast at $372,987,086, and the highest PYPD revenue forecast at $372,987,086.

In 2028, PYPD is forecast to generate $827,501,405 in revenue, with the lowest revenue forecast at $827,501,405 and the highest revenue forecast at $827,501,405.

What is PYPD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PYPD) forecast ROA is 8.49%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is PYPD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PYPD price target, the average PYPD price target is $11.00, with the highest PYPD stock price forecast at $13.00 and the lowest PYPD stock price forecast at $9.00.

On average, Wall Street analysts predict that Polypid's share price could reach $11.00 by Jun 9, 2026. The average Polypid stock price prediction forecasts a potential upside of 222.58% from the current PYPD share price of $3.41.

What is PYPD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PYPD) Polypid's current Earnings Per Share (EPS) is $4.91. On average, analysts forecast that PYPD's EPS will be -$1.88 for 2025, with the lowest EPS forecast at -$1.89, and the highest EPS forecast at -$1.87. On average, analysts forecast that PYPD's EPS will be -$0.89 for 2026, with the lowest EPS forecast at -$1.09, and the highest EPS forecast at -$0.68. In 2027, PYPD's EPS is forecast to hit -$0.51 (min: -$0.51, max: -$0.51).

What is PYPD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PYPD) forecast ROE is 27.85%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.